(SITM) Sitime - NASDAQ
Sector: Technology | Industry: Semiconductors | Exchange: NASDAQ (USA) | Market Cap: 19.599m USD | Total Return: 206.9% in 12m
Avg Turnover: 376M
Qual. Beats: 2
Rev. Trend: 86.1%
Qual. Beats: 8
Warnings
Below Avwap Earnings
Tailwinds
Rs Leader, Confidence
SiTime Corporation is a Santa Clara-based semiconductor company specializing in silicon-based timing systems. The firm designs and markets micro-electromechanical systems (MEMS) oscillators, resonators, and clock integrated circuits that serve as the heartbeat for electronic devices across automotive, aerospace, and data center sectors.
The company operates a fabless business model, outsourcing the physical manufacturing of silicon wafers to third-party foundries while focusing internal resources on high-margin design and proprietary MEMS technology. Unlike traditional quartz-based timing components, silicon MEMS solutions offer higher durability and a smaller physical footprint, making them critical for the deployment of 5G infrastructure and artificial intelligence hardware.
To evaluate how these technical advantages translate into long-term financial performance, investors can find deeper quantitative analysis on ValueRay. SiTime maintains a global footprint with significant revenue exposure to the Asia-Pacific region, reflecting the concentrated nature of the global electronics supply chain.
- High-performance timing demand in AI data centers drives top-line revenue growth
- Expansion into automotive and aerospace markets diversifies revenue away from consumer electronics
- Inventory normalization across communications and industrial segments impacts near-term sales volume
- MEMS technology displacement of traditional quartz oscillators increases total addressable market share
- Geopolitical tensions in Taiwan and China pose significant semiconductor supply chain risks
| Net Income: -24.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 5.69 > 1.0 |
| NWC/Revenue: 229.8% < 20% (prev 179.4%; Δ 50.39% < -1%) |
| CFO/TA 0.08 > 3% & CFO 103.3m > Net Income -24.2m |
| Current Ratio: 12.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.3m) vs 12m ago 11.37% < -2% |
| Gross Margin: 55.70% > 18% (prev 50.95%; Δ 4.75% > 0.5%) |
| Asset Turnover: 35.10% > 50% (prev 26.37%; Δ 8.72% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.68 (Total Current Assets 949.2m - Total Current Liabilities 76.1m) / Total Assets 1.29b |
| B: -0.18 (Retained Earnings -230.1m / Total Assets 1.29b) |
| C: -0.04 (EBIT TTM -40.6m / Avg Total Assets 1.08b) |
| D: 8.66 (Book Value of Equity 1.16b / Total Liabilities 133.9m) |
| Altman-Z'' = 12.69 = AAA |
| DSRI: 1.18 (Receivables 55.0m/28.1m, Revenue 379.9m/230.0m) |
| GMI: 0.91 (GM 50.95% / 55.70%) |
| AQI: 0.63 (AQ_t 0.18 / AQ_t-1 0.28) |
| SGI: 1.65 (Revenue 379.9m / 230.0m) |
| TATA: -0.10 (NI -24.2m - CFO 103.3m) / TA 1.29b) |
| Beneish M = -2.71 (Cap -4..+1) = A |
As of June 19, 2026, the stock is trading at USD 677.21 with a total of 389,133 shares traded.
Over the past week, the price has changed by +1.95%,
over one month by -6.67%,
over three months by +95.73% and
over the past year by +206.93%.
Sitime has received a consensus analysts rating of 3.86. Therefore, it is recommended to buy SITM.
- StrongBuy: 2
- Buy: 3
- Hold: 1
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 827.8 | 22.2% |
P/E Forward = 100.0
P/S = 51.587
P/B = 16.9102
P/EG = 3.8166
Revenue TTM = 379.9m USD
EBIT TTM = -40.6m USD
EBITDA TTM = 2.96m USD
Long Term Debt = 537k USD (estimated: total debt 2.96m - short term 2.42m)
Short Term Debt = 2.42m USD (from shortTermDebt, last quarter)
Debt = 2.96m USD (from shortLongTermDebtTotal, last quarter) (leases 2.96m already included)
Net Debt = -785.7m USD (calculated: Debt 2.96m - CCE 788.7m)
Enterprise Value = 18.8b USD (19.6b + Debt 2.96m - CCE 788.7m)
Interest Coverage Ratio = unknown (Ebit TTM -40.6m / Interest Expense TTM 0.0)
EV/FCF = 348.8x (Enterprise Value 18.8b / FCF TTM 53.9m)
FCF Yield = 0.29% (FCF TTM 53.9m / Enterprise Value 18.8b)
FCF Margin = 14.20% (FCF TTM 53.9m / Revenue TTM 379.9m)
Net Margin = -6.38% (Net Income TTM -24.2m / Revenue TTM 379.9m)
Gross Margin = 55.70% ((Revenue TTM 379.9m - Cost of Revenue TTM 168.3m) / Revenue TTM)
Gross Margin QoQ = 58.96% (prev 56.39%)
Tobins Q-Ratio = 14.55 (Enterprise Value 18.8b / Total Assets 1.29b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 2.96m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -32.1m (EBIT -40.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 12.48 (Total Current Assets 949.2m / Total Current Liabilities 76.1m)
Debt / Equity = 0.00 (Debt 2.96m / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = -265.4 (out of range, set to none) (Net Debt -785.7m / EBITDA 2.96m)
Debt / FCF = -14.57 (Net Debt -785.7m / FCF TTM 53.9m)
Total Stockholder Equity = 1.13b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.24% (Net Income -24.2m / Total Assets 1.29b)
RoE = -2.15% (Net Income TTM -24.2m / Total Stockholder Equity 1.13b)
RoCE = -3.59% (EBIT -40.6m / Capital Employed (Equity 1.13b + L.T.Debt 537k))
RoIC = -2.67% (negative operating profit) (NOPAT -32.1m / Invested Capital 1.20b)
WACC = 16.39% (E(19.6b)/V(19.6b) * Re(16.39%) + D(2.96m)/V(19.6b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 16.39% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 95.56 | Cagr: 7.15%
[DCF] Terminal Value 52.50% ; FCFF base≈53.9m ; Y1≈54.2m ; Y5≈57.4m
[DCF] Fair Price = 44.07 (EV 377.6m - Net Debt -785.7m = Equity 1.16b / Shares 26.4m; r=16.39% [WACC]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 2.95 | # QB: 2
Revenue Correlation: 86.08 | Revenue CAGR: 36.83% | SUE: 3.03 | # QB: 8
EPS current Quarter (2026-06-30): EPS=1.96 | Chg30d=+66.69% | Revisions=+14% | Analysts=9
EPS next Quarter (2026-09-30): EPS=2.14 | Chg30d=+57.88% | Revisions=+50% | Analysts=9
EPS current Year (2026-12-31): EPS=7.85 | Chg30d=+51.32% | Revisions=+50% | GrowthEPS=+145.3% | GrowthRev=+83.9%
EPS next Year (2027-12-31): EPS=10.66 | Chg30d=+61.60% | Revisions=+50% | GrowthEPS=+35.8% | GrowthRev=+31.8%
[Analyst] Revisions Ratio: +50%